Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative

Mark V Mishra1, Eli D Scher, Jocelyn Andrel

  • 1*Department of Radiation Oncology †Robert Wood Johnson School of Osteopathic Medicine, University of Medicine & Dentistry of New Jersey, New Brunswick, NJ ‡Department of Pharmacology and Experimental Therapeutics, Division of Biostatistics §Department of Urology, Kimmel Cancer Center, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA.

Abstract